Escalon Medical Corp
Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or … Read more
Escalon Medical Corp (ESMC) - Total Assets
Latest total assets as of September 2025: $4.58 Million USD
Based on the latest financial reports, Escalon Medical Corp (ESMC) holds total assets worth $4.58 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Escalon Medical Corp - Total Assets Trend (2000–2025)
This chart illustrates how Escalon Medical Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Escalon Medical Corp - Asset Composition Analysis
Current Asset Composition (June 2025)
Escalon Medical Corp's total assets of $4.58 Million consist of 92.4% current assets and 7.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 10.9% |
| Accounts Receivable | $1.50 Million | 30.1% |
| Inventory | $2.14 Million | 42.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $29.79K | 0.6% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2000–2025)
This chart illustrates how Escalon Medical Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Escalon Medical Corp's current assets represent 92.4% of total assets in 2025, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 10.9% of total assets in 2025, up from 1.1% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 86.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 42.9% of total assets.
Escalon Medical Corp Competitors by Total Assets
Key competitors of Escalon Medical Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Escalon Medical Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Escalon Medical Corp generates 2.41x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Escalon Medical Corp generates $ 2.11 in net profit.
Escalon Medical Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.67 | 1.66 | 1.44 |
| Quick Ratio | 0.98 | 0.99 | 1.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.69 Million | $ 1.77 Million | $ 1.35 Million |
Escalon Medical Corp - Advanced Valuation Insights
This section examines the relationship between Escalon Medical Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.40 |
| Latest Market Cap to Assets Ratio | 0.23 |
| Asset Growth Rate (YoY) | 4.9% |
| Total Assets | $4.99 Million |
| Market Capitalization | $1.16 Million USD |
Valuation Analysis
Below Book Valuation: The market values Escalon Medical Corp's assets below their book value (0.23 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Escalon Medical Corp's assets grew by 4.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Escalon Medical Corp (2000–2025)
The table below shows the annual total assets of Escalon Medical Corp from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $4.99 Million | +4.94% |
| 2024-06-30 | $4.76 Million | -10.36% |
| 2023-06-30 | $5.31 Million | +2.62% |
| 2022-06-30 | $5.17 Million | -8.99% |
| 2021-06-30 | $5.68 Million | -0.69% |
| 2020-06-30 | $5.72 Million | +11.61% |
| 2019-06-30 | $5.13 Million | -5.52% |
| 2018-06-30 | $5.43 Million | +8.88% |
| 2017-06-30 | $4.98 Million | -9.88% |
| 2016-06-30 | $5.53 Million | -15.55% |
| 2015-06-30 | $6.55 Million | -14.46% |
| 2014-06-30 | $7.66 Million | +5.28% |
| 2013-06-30 | $7.27 Million | -25.42% |
| 2012-06-30 | $9.75 Million | -43.49% |
| 2011-06-30 | $17.25 Million | -21.59% |
| 2010-06-30 | $22.01 Million | -12.17% |
| 2009-06-30 | $25.05 Million | -21.45% |
| 2008-06-30 | $31.90 Million | -29.15% |
| 2007-06-30 | $45.02 Million | +16.49% |
| 2006-06-30 | $38.65 Million | -3.51% |
| 2005-06-30 | $40.05 Million | +35.96% |
| 2004-06-30 | $29.46 Million | +74.40% |
| 2003-06-30 | $16.89 Million | -0.13% |
| 2002-06-30 | $16.91 Million | -4.98% |
| 2001-06-30 | $17.80 Million | +5.66% |
| 2000-06-30 | $16.84 Million | -- |